Agile Therapeutics, Inc. Restructuring Charges
Agile Therapeutics, Inc. reported Restructuring Charges of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2021-03-01
- Agile Therapeutics, Inc. restructuring charges for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- Agile Therapeutics, Inc. restructuring charges for the quarter ending 2019-03-31 was $0.00.
- Agile Therapeutics, Inc. restructuring charges for the quarter ending 2018-12-31 was $304.00K.
- Agile Therapeutics, Inc. restructuring charges for the quarter ending 2018-09-30 was $299.00K.
- Agile Therapeutics, Inc. restructuring charges for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Agile Therapeutics, Inc. restructuring charges for fiscal 2018 was $1.02M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-20 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $304.00K derived: sum of 3 quarters · filed 2021-03-01 | $603.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-03 | $304.00K derived: sum of 2 quarters · filed 2021-03-01 | $603.00K derived: sum of 3 quarters · filed 2021-03-01 | $1.02M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $603.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.02M derived: sum of 3 quarters · filed 2021-03-01 | $1.02M 10-K · filed 2021-03-01 |
| 2018-09-30 | $299.00K 10-Q · filed 2019-10-28 | $715.00K derived: sum of 2 quarters · filed 2019-10-28 | $715.00K 10-Q · filed 2019-10-28 | |
| 2018-06-30 | $416.00K 10-Q · filed 2019-08-01 | $416.00K 10-Q · filed 2019-08-01 |